Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Intratumoral metabolic heterogeneity of cervical cancer
Elizabeth A. Kidd,
Perry W. Grigsby
Institute of Clinical and Translational Sciences (ICTS)
Division of Nuclear Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
139
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Intratumoral metabolic heterogeneity of cervical cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cervical Cancer
100%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
100%
Metabolic Heterogeneity
100%
Tumor
50%
Working Diagnosis
50%
Tumor Volume
50%
Cervix
50%
Fluorodeoxyglucose
50%
Pelvic Recurrence
50%
Progression-free Survival
25%
Patient Outcomes
25%
Tumor Heterogeneity
25%
Disease Outcome
25%
Response to Therapy
25%
Three-dimensional (3D)
25%
Prospective Cohort Study
25%
Lymph Node Metastasis
25%
Lymph Node Involvement
25%
Standardized Uptake Value
25%
Obstetrics
25%
Cervical Tumor
25%
Tumor Histology
25%
International Federations
25%
Tumor-specific
25%
Tumor Response
25%
Chemoradiation
25%
Specific Patient
25%
Specific Factors
25%
Adaptive Thresholding
25%
Response to Radiation
25%
Intratumoral Heterogeneity
25%
Image Segmentation
25%
Positron Emission Tomography/computerized Tomography
25%
Risk Response
25%
Volume Threshold
25%
Threshold Function
25%
F-18 Fluorodeoxyglucose Positron Emission Tomography
25%
Medicine and Dentistry
Cervical Cancer
100%
Fluorodeoxyglucose
100%
Positron Emission Tomography
83%
Neoplasm
66%
Pelvis
33%
Recurrent Disease
33%
Uterine Cervix Tumor
33%
Progression Free Survival
16%
Obstetrics
16%
Lymph Node
16%
Computer Assisted Tomography
16%
Prospective Cohort Study
16%
Lymph Node Metastasis
16%
Gynecology
16%
Standardized Uptake Value
16%
Fluorodeoxyglucose F 18
16%
Tumor Histology
16%
Specific Tumor
16%
Chemoradiotherapy
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Uterine Cervix Cancer
100%
Fluorodeoxyglucose
100%
Recurrent Disease
33%
Uterine Cervix Tumor
33%
Progression Free Survival
16%
Chemoradiation Therapy
16%
Prospective Cohort Study
16%
Lymph Node Metastasis
16%
Fluorodeoxyglucose F 18
16%
Diseases
16%
Immunology and Microbiology
Positron Emission Tomography
100%
Lymph Node
40%
Pelvis
40%
Tumor Volume
40%
Computer Assisted Tomography
20%
Progression Free Survival
20%